Dr. Rohan Gopalani, MD

NPI: 1972640183
Total Payments
$1,475
2024 Payments
$155.75
Companies
17
Transactions
83
Medicare Patients
316
Medicare Billing
$79,891

Payment Breakdown by Category

Food & Beverage$1,468 (99.5%)
Education$6.98 (0.5%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,468 81 99.5%
Education $6.98 2 0.5%

Top Paying Companies

Company Total Records Latest Year
Sunovion Pharmaceuticals Inc. $292.56 17 $0 (2020)
Otsuka America Pharmaceutical, Inc. $210.01 13 $0 (2024)
Shire North American Group Inc $197.53 13 $0 (2018)
Allergan Inc. $122.97 10 $0 (2017)
Neos Therapeutics, LP $112.10 6 $0 (2017)
Janssen Pharmaceuticals, Inc $90.40 3 $0 (2024)
Takeda Pharmaceuticals America, Inc. $79.37 2 $0 (2017)
Neurocrine Biosciences, Inc. $70.21 3 $0 (2024)
Vanda Pharmaceuticals Inc. $60.85 3 $0 (2017)
ABBVIE INC. $47.98 2 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $155.75 6 Neurocrine Biosciences, Inc. ($54.94)
2023 $37.52 1 Janssen Pharmaceuticals, Inc ($37.52)
2022 $42.92 2 ABBVIE INC. ($23.45)
2021 $24.53 1 AbbVie Inc. ($24.53)
2020 $40.78 2 Sunovion Pharmaceuticals Inc. ($40.78)
2019 $77.01 4 Sunovion Pharmaceuticals Inc. ($42.30)
2018 $47.31 3 Sunovion Pharmaceuticals Inc. ($33.77)
2017 $1,049 64 Otsuka America Pharmaceutical, Inc. ($185.05)

All Payment Transactions

83 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
10/24/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $30.56 General
Category: Neuropsychiatry
09/19/2024 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $22.97 General
Category: Neurology
07/25/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $28.35 General
Category: Neuroscience
05/15/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $24.53 General
Category: Neuroscience
05/02/2024 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug) Food and Beverage In-kind items and services $24.96 General
Category: PSYCHIATRY
03/22/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $24.38 General
Category: Neuropsychiatry
09/21/2023 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $37.52 General
Category: Neuroscience
06/16/2022 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $19.47 General
Category: PSYCHIATRY
04/21/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $23.45 General
Category: NEUROSCIENCE
11/18/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $24.53 General
Category: NEUROSCIENCE
11/12/2020 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $21.23 General
Category: CNS
06/11/2020 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $19.55 General
Category: CNS
12/12/2019 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $19.44 General
Category: CNS
11/20/2019 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $23.04 General
Category: CNS
05/01/2019 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $19.26 General
Category: CNS
04/11/2019 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $15.27 General
Category: NEUROLOGY
11/29/2018 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $18.10 General
Category: CNS
08/29/2018 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $15.67 General
Category: CNS
01/24/2018 Shire North American Group Inc MYDAYIS (Drug) Food and Beverage In-kind items and services $13.54 General
Category: NEUROSCIENCE
12/14/2017 Neos Therapeutics, LP Adzenys XR-ODT (Drug) Food and Beverage In-kind items and services $20.88 General
Category: ADHD
12/12/2017 Merck Sharp & Dohme Corporation BELSOMRA (Drug) Food and Beverage In-kind items and services $10.60 General
Category: NEUROSCIENCE
12/01/2017 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $17.04 General
Category: CNS
11/15/2017 Shire North American Group Inc MYDAYIS (Drug) Food and Beverage In-kind items and services $15.91 General
Category: NEUROSCIENCE
11/14/2017 Shire North American Group Inc MYDAYIS (Drug) Food and Beverage In-kind items and services $13.08 General
Category: NEUROSCIENCE
11/07/2017 Neos Therapeutics, LP Adzenys XR-ODT (Drug) Food and Beverage In-kind items and services $2.06 General
Category: ADHD

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 93 843 $108,167 $37,130
2022 3 120 804 $94,183 $27,349
2021 1 21 96 $10,560 $2,776
2020 4 82 325 $40,869 $12,636
Total Patients
316
Total Services
2,068
Medicare Billing
$79,891
Procedure Codes
12

All Medicare Procedures & Services

12 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 43 676 $80,600 $25,891 32.1%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 15 131 $18,969 $7,950 41.9%
90792 Psychiatric diagnostic evaluation with medical services Facility 2023 15 15 $4,440 $1,964 44.2%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 20 21 $4,158 $1,324 31.8%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 71 754 $82,940 $22,816 27.5%
90792 Psychiatric diagnostic evaluation with medical services Facility 2022 23 23 $6,302 $3,004 47.7%
99238 Hospital discharge day management, 30 minutes or less Facility 2022 26 27 $4,941 $1,530 31.0%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2021 21 96 $10,560 $2,776 26.3%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2020 40 281 $30,910 $8,853 28.6%
90792 Psychiatric diagnostic evaluation with medical services Facility 2020 16 17 $4,658 $1,912 41.0%
99239 Hospital discharge day management, more than 30 minutes Facility 2020 12 12 $2,556 $981.08 38.4%
99238 Hospital discharge day management, 30 minutes or less Facility 2020 14 15 $2,745 $889.97 32.4%

About Dr. Rohan Gopalani, MD

Dr. Rohan Gopalani, MD is a Child & Adolescent Psychiatry healthcare provider based in Ambler, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1972640183.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rohan Gopalani, MD has received a total of $1,475 in payments from pharmaceutical and medical device companies, with $155.75 received in 2024. These payments were reported across 83 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,468).

As a Medicare-enrolled provider, Gopalani has provided services to 316 Medicare beneficiaries, totaling 2,068 services with total Medicare billing of $79,891. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.

Practice Information

  • Specialty Child & Adolescent Psychiatry
  • Location Ambler, PA
  • Active Since 01/30/2007
  • Last Updated 07/18/2011
  • Taxonomy Code 2084P0804X
  • Entity Type Individual
  • NPI Number 1972640183

Products in Payments

  • LATUDA (Drug) $292.56
  • VRAYLAR (Drug) $170.95
  • VYVANSE (Drug) $112.86
  • Adzenys XR-ODT (Drug) $112.10
  • ABILIFY MAINTENA (Drug) $108.78
  • INVEGA SUSTENNA (Drug) $90.40
  • MYDAYIS (Drug) $84.67
  • Trintellix (Drug) $79.37
  • REXULTI (Drug) $76.27
  • INGREZZA (Drug) $70.21
  • Fanapt (Drug) $38.57
  • Aptensio XR (Drug) $34.33
  • ABILIFY ASIMTUFII (Drug) $24.96
  • Aristada 441 mg (Drug) $24.38
  • UZEDY (Drug) $22.97
  • BELSOMRA (Drug) $21.20
  • CAPLYTA (Drug) $19.47
  • ARISTADA (Drug) $19.44
  • QUILLICHEW ER (Drug) $18.51
  • TRINTELLIX (Drug) $16.89

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Child & Adolescent Psychiatry Doctors in Ambler